MedPath

sumatriptan succinate

Sumatriptan Succinate Injection

Approved
Approval ID

05adc16c-4c2b-46f0-b810-bb18d4106dc5

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 4, 2009

Manufacturers
FDA

JHP Pharmaceuticals LLC

DUNS: 804894611

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

sumatriptan succinate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code42023-121
Application NumberANDA077871
Product Classification
M
Marketing Category
C73584
G
Generic Name
sumatriptan succinate
Product Specifications
Route of AdministrationSUBCUTANEOUS
Effective DateSeptember 4, 2009
FDA Product Classification

INGREDIENTS (3)

sumatriptan succinateActive
Quantity: 6 mg in 0.5 mL
Code: J8BDZ68989
Classification: ACTIM
sodium chlorideInactive
Quantity: 3.5 mg in 0.5 mL
Code: 451W47IQ8X
Classification: IACT
waterInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

sumatriptan succinate - FDA Drug Approval Details